According to an Amneal release, lisdexamfetamine dimesylate capsules are a generic version of Vyvanse (Takeda Pharmaceuticals), which is currently on the FDA shortage product list. Amneal received FDA approval for the capsules in doses ranging from 20 mg to 70 mg and has already started releasing supply to the market.